SCHEMBL7347654

SCHEMBL7347654

C#CCN(C)C(C)(C)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 8/20 0.47
MAOA P21397 7/20 0.47
PYCR1 P32322 5/20 0.47
LMNA P02545 2/20 0.47
TSHR P16473 2/20 0.47
USP2 O75604 1/20 0.47
CYP3A4 P08684 1/20 0.47
ALDH1A1 P00352 1/20 0.46
BLM P54132 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CYP1A2 P05177 2/20 0.42
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
ADRA1A P35348 1/20 0.42
SNCA P37840 1/20 0.42
OPRK1 P41145 1/20 0.42
CYP2D6 P10635 1/20 0.42
PKM P14618 1/20 0.42
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7355367 0.98 LMNA (0.49) MAOBMAOAPYCR1LMNATSHR
SCHEMBL8353879 0.83 PYCR1 (0.49) MAOBMAOAPYCR1LMNATSHR
SCHEMBL23423652 0.75 KCNN4 (0.44) LMNAALDH1A1SMN1; SMN2CYP2D6MAPK1
SCHEMBL20844607 0.74 TAAR1 (0.50) ALDH1A1SMN1; SMN2CYP2D6MAPK1KCNN4
SCHEMBL13061198 0.72 SMN1; SMN2 (0.48) LMNAALDH1A1SMN1; SMN2ADRA1AOPRK1
SCHEMBL12566248 0.72 KDM4E (0.47) LMNAALDH1A1SMN1; SMN2CYP2D6MAPK1
SCHEMBL23374742 0.71 CYP2D6 (0.46) CYP3A4ALDH1A1OPRK1CYP2D6MAPK1
SCHEMBL1149712 0.69 KCNN4 (0.59) LMNATSHRCYP3A4ALDH1A1SMN1; SMN2
SCHEMBL8084282 0.69 TAAR1 (0.55)
SCHEMBL12478391 0.68 SIGMAR1 (0.41) LMNAALDH1A1SMN1; SMN2CYP2D6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1773297-B1 INFUSION AND INJECTION SOLUTION OF LEVODOPA DIZLIN MEDICAL DESIGN AB (SE) 2015-01-14 EP claimed
EP-0975366-A1 CYTOPROTECTIVE AGENTS COMPRISING MONOAMINE OXIDASE INHIBITORS THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 2000-02-02 EP claimed
WO-1998040102-A1 CYTOPROTECTIVE AGENTS COMPRISING MONOAMINE OXIDASE INHIBITORS THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 1998-09-17 WO claimed
EP-3914332-A2 DEVICE AND METHOD FOR DELIVERING A FLOWABLE INGESTIBLE MEDICAMENT INTO THE GASTROINTESTINAL TRACT OF A USER Vibrant Ltd. (IL) 2021-12-01 EP disclosed
EP-3906086-A1 DEVICE AND METHOD FOR DELIVERING AN INGESTIBLE MEDICAMENT INTO THE GASTROINTESTINAL TRACT OF A USER Vibrant Ltd. (IL) 2021-11-10 EP disclosed
WO-2020141469-A1 DEVICE AND METHOD FOR DELIVERING AN INGESTIBLE MEDICAMENT INTO THE GASTROINTESTINAL TRACT OF A USER VIBRANT LTD. (IL) 2020-07-09 WO disclosed
WO-2019197964-A1 VIBRATING CAPSULE FOR ENHANCING ABSORPTION OF INGESTED MEDICAMENTS VIBRANT LTD. (IL) 2019-10-17 WO disclosed
EP-0975366-A1 CYTOPROTECTIVE AGENTS COMPRISING MONOAMINE OXIDASE INHIBITORS THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 2000-02-02 EP disclosed
WO-1998040102-A1 CYTOPROTECTIVE AGENTS COMPRISING MONOAMINE OXIDASE INHIBITORS THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN (IE) 1998-09-17 WO disclosed